Christine Hsu MD

Dr. Christine Hsu is an Assistant Research Physician and staff clinician in the Liver Disease Branch at National Institute of Diabetes and Digestive and Kidney Diseases and is currently the associate program director for the hepatology fellowship.  Prior to that she was a transplant hepatologist at Georgetown University.  She continues to have a joint faculty appointment as an Assistant Professor at Georgetown University.  Her research interests include improving outcomes of patients with alcohol associated liver disease and hepatocellular carcinoma.  She was one of the first members of the ACCELERATE-AH (American Consortium of Early Liver Transplantation for Alcohol Associated Hepatitis) and to publish U.S. outcomes of early liver transplantation in patients with severe alcohol-associated hepatitis without a defined period of sobriety.  Subsequently, the consortium has also developed a SALT score, which has a high negative predictive value for return to drinking for patients transplanted for indications of alcohol associated liver disease.  She is an active member of the consortium and recently published on outcomes of alcohol associated hepatitis patients who are declined for transplant. 

She obtained her Bachelor of Science at Massachusetts Institute of Technology and went to Sidney Kimmel Medical College (previously Thomas Jefferson Medical College) for medical school. She completed her internal medicine training at Boston University Medical Center and gastroenterology and transplant hepatology fellowships at New York Presbyterian Columbia University Medical Center.  While on faculty at Georgetown, she was selected to be in the Medstar Research Scholars Program and received a new investigator award from Medstar Health Research Institute to study collagen alignment in hepatocellular carcinoma.  She also was previously a recipient of the Advanced/Transplant Hepatology Award from AASLD (American Association for Study of Liver Disease).